U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 208610

BAXDELA (DELAFLOXACIN MEGLUMINE)
EQ 450MG BASE
Marketing Status: Prescription
Active Ingredient: DELAFLOXACIN MEGLUMINE
Proprietary Name: BAXDELA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 450MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N208610
Product Number: 001
Approval Date: Jun 19, 2017
Applicant Holder Full Name: MELINTA SUBSIDIARY CORP
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top